PAROXETINE HYDROCHLORIDE | A203854 | PRINSTON PHARMACEUTICAL INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from George W. Murgatroyd III FDA-2025-P-3263 · 41 docket documents George W. Murgatroyd III filed this citizen petition under 21 CFR 10.30 requesting that the FDA publicly disavow the 2001 Keller article in the Journal of the American Academy of Child & Adolescent Psychiatry regarding paroxetine (Paxil) for adolescent depression, issue a Drug Safety Communication w | Other | 2025-08-20 | Denied | George W. Murgatroyd III |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1037
per ea
Lowest NADAC/Unit
$0.0643
per ea
Brand NDCs
0
Generic NDCs
16
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 43547035003PAROXETINE HCL 40 MG TABLET | $0.1037 | EA | Generic | — | 2026-06-17 |
| 43547035050PAROXETINE HCL 40 MG TABLET | $0.1037 | EA | Generic | — | 2026-06-17 |
| 43547035011PAROXETINE HCL 40 MG TABLET | $0.1037 | EA | Generic | — | 2026-06-17 |
| 43547035009PAROXETINE HCL 40 MG TABLET | $0.1037 | EA | Generic | — | 2026-06-17 |
| 43547034903PAROXETINE HCL 30 MG TABLET | $0.0947 | EA | Generic | — | 2026-06-17 |
| 43547034909PAROXETINE HCL 30 MG TABLET | $0.0947 | EA | Generic | — | 2026-06-17 |
Showing 6 of 16 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.